A Blind Self Controlled Multicenter Clinical Trial on the Effectiveness and Safety of Noninvasive Flow Reserve Score Analysis Software for Coronary Angiography

  • STATUS
    Recruiting
  • participants needed
    340
  • sponsor
    Second Affiliated Hospital, School of Medicine, Zhejiang University
Updated on 19 February 2024
stenosis
angiography
computed tomography angiography
coronary ct

Summary

This is a blind evaluation, self-control, multicenter clinical trial. 340 patients who need selective operation to evaluate the function of coronary artery were selected and measured with ctffr and FFR. The data of the experimental group was defined as: FFR value at the distal end of stenosis was obtained by calculating the original DICOM data of coronary CT angiography (CCTA) before operation with the non-invasive blood flow reserve analysis software of Hangzhou ArteryFlow Technology Co., Ltd. The gold standard group data is the clinical measured FFR (clinical gold standard) at the stenosis lesions. It is defined that when the coronary artery reaches the maximum congestion state, the pressure value at the distal end of the stenosis lesions is accurately measured by the guide wire with a pressure sensor, and the ratio value with the coronary mouth pressure is the FFR. By comparing the data of the experimental group and the data of the gold standard group, the effectiveness and safety of the devices in the experimental group were evaluated.

Details
Condition Coronary heart disease
Age 18-75 years
Clinical Study IdentifierNCT04426396
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

The age is 18-75 years old (including 18 and 75 years old)
Subjects with clinical need and consent for coronary angiography
Can provide the results of coronary CT angiography within 60 days or agree to carry out coronary CT angiography
The subjects knew about the experiment and signed the informed consent voluntarily

Exclusion Criteria

Patients who have had percutaneous coronary intervention (PCI)
Patients who had CABG
Acute coronary syndrome, such as acute ST segment elevation
Severe tachycardia or arrhythmia
Patients with severe hepatorenal insufficiency
Patients with congenital heart disease, implanted pacemaker or defibrillator, artificial heart valve
Failure to perform invasive FFR examination or obtain FFR value due to various reasons
Allergic to - blockers, nitrates and adenosine, sick sinus syndrome, long QT syndrome, severe hypotension, severe asthma, severe COPD or COPD
Persistent or significant clinical instability, including acute chest pain (sudden onset), cardiogenic shock, blood pressure instability (systolic blood pressure < 90mmHg) and severe congestive heart failure (according to the heart classification of the New York Heart Association, grade III or IV of cardiac function) or acute pulmonary edema
The CTA images of coronary artery showed that the stenosis rate was less than 30% or more than 90%, or the diameter of diseased segment was less than 2.0mm
Ct-ffr can not be calculated because of the quality of CTA image
Known pregnant and lactating women
Having participated in other clinical trials within 3 months
Other situations that the researchers judged were not suitable for inclusion
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.